Status:

UNKNOWN

Effect of Intranasal Mupirocin on Rate of Staphylococcus Aureus Surgical Site Infection Following Cesarean Sections

Lead Sponsor:

Hillel Yaffe Medical Center

Conditions:

Surgical Wound Infection

Cesarean Section

Eligibility:

FEMALE

Phase:

NA

Brief Summary

The investigators believe that irradication of nose colonization of staphyloccocus aureus will reduce the incidence of surgical site infections after cesarean section.

Eligibility Criteria

Inclusion

  • Women assigned to undergo cesarean section

Exclusion

  • All others

Key Trial Info

Start Date :

July 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2014

Estimated Enrollment :

400 Patients enrolled

Trial Details

Trial ID

NCT01152593

Start Date

July 1 2010

End Date

December 1 2014

Last Update

June 29 2010

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hillel Yaffe Medical Center

Hadera, Israel, 38100

Effect of Intranasal Mupirocin on Rate of Staphylococcus Aureus Surgical Site Infection Following Cesarean Sections | DecenTrialz